文献速递心血管MR

肥厚型心肌病患者右心室肥厚的预后意义

Prognostic Implication of Right Ventricular Hypertrophy in Patients With Hypertrophic Cardiomyopathy.
PubMed 文献 · Korean J Radiol · 2025-09-24

本回顾性研究纳入2007至2019年间接受心脏磁共振和超声心动图检查的320例肥厚型心肌病患者,右心室肥厚定义为右心室壁厚度≥5 mm。中位随访7.7年,右心室肥厚是心力衰竭住院(HR=3.19,95%CI=1.23-8.28,P=0.017)和复合不良事件(HR=2.38,95%CI=1.01-5.64,P=0.048)的独立预测因子。将右心室肥厚纳入5年心脏性猝死风险模型后,Harrell C指数显著提高,提示常规双心室评估的重要性。

要点

  • 心脏磁共振检出的右心室肥厚(右心室壁厚度≥5 mm)是肥厚型心肌病患者心力衰竭住院和复合不良事件的独立预测因子。
  • 将右心室肥厚纳入5年心脏性猝死风险模型后,Harrell C指数显著提高(心力衰竭住院0.606升至0.688,P=0.033;复合事件0.641升至0.727,P=0.030)。
  • 肥厚型心肌病评估中应常规进行双心室评估,以识别右心室肥厚这一高风险征象。

核心结论

  • 心脏磁共振检出的右心室肥厚可独立预测肥厚型心肌病患者的不良事件,将其纳入常规风险模型可能提高预测性能,支持在肥厚型心肌病评估中常规进行双心室评估的重要性。

研究设计与样本

  • 回顾性研究,纳入2007至2019年间接受心脏磁共振和超声心动图检查的320例肥厚型心肌病患者,采用Kaplan-Meier生存分析、Cox比例风险回归及模型性能指标(包括5年随访的时间依赖ROC曲线分析和Harrell C指数)评估右心室肥厚的预后作用。

关键影像表现/征象

  • 右心室肥厚定义为右心室壁厚度≥5 mm,320例患者中65例(20.1%)存在右心室肥厚。
  • 中位随访7.7年期间,28例(8.8%)发生心力衰竭住院,34例(10.6%)发生复合不良事件。

诊断标准与关键数值

  • 右心室肥厚定义为心脏磁共振测量的右心室壁厚度≥5 mm。
  • 多变量Cox模型显示,右心室肥厚预测心力衰竭住院的HR=3.19(95%CI=1.23-8.28,P=0.017),预测复合事件的HR=2.38(95%CI=1.01-5.64,P=0.048)。
  • 将右心室肥厚纳入5年心脏性猝死风险模型后,时间依赖AUC从0.620升至0.725(心力衰竭住院,P=0.057),从0.712升至0.848(复合事件,P=0.062),差异均未达统计学显著。
  • Harrell C指数显著提高:心力衰竭住院从0.606升至0.688(P=0.033),复合事件从0.641升至0.727(P=0.030)。

临床应用与阅片要点

  • 在肥厚型心肌病患者的心脏磁共振阅片和报告中,应测量并报告右心室壁厚度,关注是否达到≥5 mm的右心室肥厚标准。
  • 右心室肥厚可作为肥厚型心肌病患者心力衰竭住院和复合不良事件的独立风险分层指标。
  • 将右心室肥厚信息纳入常规风险模型可能改善预测性能,支持在肥厚型心肌病评估中常规进行双心室评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the prognostic significance of right ventricular hypertrophy (RVH) in patients with hypertrophic cardiomyopathy (HCM) using cardiac magnetic resonance imaging (CMR) and to assess its incremental value when incorporated into the established 5-year sudden cardiac death (SCD) risk prediction model.

MATERIALS AND METHODS: This retrospective study included 320 patients with HCM who underwent CMR and echocardiography between 2007 and 2019. RVH was defined as a right ventricular wall thickness of ≥5 mm. The primary event was heart failure (HF) hospitalization. The secondary events were a composite of HF hospitalization, cardiovascular death, and heart transplantation. The prognostic role of RVH was assessed using Kaplan-Meier survival analysis, Cox proportional hazards regression, and model performance metrics, including time-dependent receiver operating characteristic curve analysis for a 5-year follow-up and Harrell's C-index.

RESULTS: Among 320 patients (mean age 57.5 ± 12.8 years; 66.3% men), 65 (20.1%) had RVH. Over a median follow-up of 7.7 years, 28 (8.8%) patients experienced HF hospitalization, and 34 (10.6%) experienced composite adverse events. In multivariable Cox models, RVH was an independent predictor of both events: HF hospitalization (hazard ratio [HR] = 3.19, 95% confidence interval [CI] = 1.23-8.28, P = 0.017) and the composite events (HR = 2.38, 95% CI = 1.01-5.64, P = 0.048). Incorporating RVH into the 5-year SCD risk model increased the time-dependent area under the curve, though not significant, from 0.620 to 0.725 for HF hospitalization (P = 0.057) and from 0.712 to 0.848 for composite events (P = 0.062). Harrell's C-index improved significantly from 0.606 to 0.688 (P = 0.033) and from 0.641 to 0.727 (P = 0.030), respectively.

CONCLUSION: CMR-detected RVH independently predicts adverse events in patients with HCM. Incorporating RVH into a conventional risk model may enhance its predictive performance, supporting the importance of routine biventricular assessments in HCM evaluation.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Hong SH, Park EA, Kwak SG, et al. Prognostic Implication of Right Ventricular Hypertrophy in Patients With Hypertrophic Cardiomyopathy. Korean J Radiol. 2025. PMID: 41078016. doi:10.3348/kjr.2025.0301

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。